MetaCap

Damora Therapeutics Insider Trades

NASDAQ: DMRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

21.08+0.52 (+2.53%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

After hours: 21.08 0.00%

Last 12 months

Purchases
1 · $252.88K
Sales
4 · $30.65K
Shares bought / sold
12.50K / 1.33K
Net activity
Net buying $222,222

Damora Therapeutics insider activity

Over the last 12 months, Damora Therapeutics insiders reported 15 transactions on SEC Form 4: 1 open-market purchase and 4 sales. Insiders bought $252,875 and sold $30,653 worth of stock, for net insider buying of $222,222. The largest seller was Schambye Hans T., with $14,966 in reported sales.

The most recent filing shows Jarrett Jennifer (Director, President and CEO) buying 12,500 shares at $20.23 on Sep 25, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put DMRA's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

DMRA insider transactions

Damora Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Sep 25, 2026Jarrett JenniferDirector, President and CEOBuy12,500$252.88KForm 4
Jul 6, 2026Winslow GarrettGeneral CounselSale245$7.35KForm 4
Jul 3, 2026Winslow GarrettGeneral CounselOption exercise680—Form 4
Mar 30, 2026Jarrett JenniferSee RemarksAward500,000—Form 4
Feb 9, 2026Fairmount Funds Management LLC & Fairmount Healthcare Fund II L.P. & Fairmount Healthcare Co-Invest V L.P. & Kiselak Tomas & Harwin Peter EvanDirectorOption exercise2,904,000—Form 4
Feb 9, 2026Fairmount Funds Management LLC & Fairmount Healthcare Fund II L.P. & Fairmount Healthcare Co-Invest V L.P. & Kiselak Tomas & Harwin Peter EvanDirectorOption exercise5,809,000—Form 4
Feb 9, 2026Bruno JulianneDirectorOption exercise129,000—Form 4
Jan 5, 2026Hewes L. BeckerChief Medical OfficerAward264,629—Form 4
Jan 5, 2026Sattarzadeh SherwinChief Operating OfficerAward190,376—Form 4
Jan 2, 2026Firmani LoriChief Financial OfficerSale135$2.89KForm 4
Jan 2, 2026Firmani LoriChief Financial OfficerOption exercise374—Form 4
Jan 2, 2026Winslow GarrettGeneral CounselSale255$5.45KForm 4
Jan 2, 2026Winslow GarrettGeneral CounselOption exercise680—Form 4
Jan 2, 2026Schambye Hans T.Chief Executive OfficerSale700$14.97KForm 4
Jan 2, 2026Schambye Hans T.Chief Executive OfficerOption exercise1,360—Form 4
Jul 3, 2025Firmani LoriInterim CFOSale147$498.33Form 4
Jul 3, 2025Firmani LoriInterim CFOOption exercise374—Form 4
Jul 3, 2025Schambye Hans T.Chief Executive OfficerSale735$2.48KForm 4
Jul 3, 2025Schambye Hans T.Chief Executive OfficerOption exercise1,360—Form 4
Jul 3, 2025Winslow GarrettGeneral CounselSale260$881.40Form 4
Jul 3, 2025Winslow GarrettGeneral CounselOption exercise680—Form 4
Jan 3, 2025Firmani LoriInterim CFOSale261$1.47KForm 4
Jan 3, 2025Firmani LoriInterim CFOOption exercise726—Form 4
Jan 3, 2025Winslow GarrettGeneral CounselSale471$2.64KForm 4
Jan 3, 2025Winslow GarrettGeneral CounselOption exercise1,320—Form 4
Jan 3, 2025Schambye Hans T.Chief Executive OfficerSale1,341$7.51KForm 4
Jan 3, 2025Schambye Hans T.Chief Executive OfficerOption exercise2,640—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related